Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the  Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfill our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free more...


Article type

Original Article


Article page

194-198


Authors Details

Ram Yash Singh Yadav, Anil Kumar*, Ram Kumar, Ashutosh Kumar Singh, Chiranjee Rai


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 73

PDF Downloaded: 67


To study early and late effect of intravitreal injection Ranibizumab on Cystoid Macular Edema(CME) due to Branch Retinal Vein Occlusion (BRVO)


Original Article

Author Details : Ram Yash Singh Yadav, Anil Kumar*, Ram Kumar, Ashutosh Kumar Singh, Chiranjee Rai

Volume : 7, Issue : 1, Year : 2021

Article Page : 194-198

https://doi.org/10.18231/j.ijceo.2021.041



Suggest article by email


Abstract

Objective: To study early and late effect of intravitreal injection Ranibizumab on Cystoid Macular Edema(CME) because of Branch Retinal Vein Occlusion (BRVO).
Materials and Methods: This Study included 25 Patients (age group18 year) with cystoid macular edema because of branch retinal vein occlusion attending to department of ophthalmology Nehru Chikitsalaya, B.R.D. Medical college, Gorakhpur. An observational study has been concluded in which early and late effect of intravitreal injection Ranibizumab on cystoid macular edema because of branch retinal vein occlusion.
Result: The mean age group being 58.53 year of total 25 patients with 13 male and 12 female patients with no dropout throughout the study. In 1 month of post injecton observation, 10 (40%) patients who presented within 1 month of onset of BRVO showed more gain in visual acuity and more reduction in central macular thickness (CMT) as compare to 15 (60%) patients who presented after 1 month of onset of BRVO.
Conclusion: Intravitreal Ranibizumab is more effective in patients presented early than late in improving best corrected visual acuity ( BCVA) and decreasing CMT.

Keywords: Best corrected visual acuity, Branch retinal vein occlusion, Central macular thickness, Cystoid macular edema, Intravitreal ranabizumab.


How to cite : Yadav R Y S, Kumar A , Kumar R, Singh A K, Rai C , To study early and late effect of intravitreal injection Ranibizumab on Cystoid Macular Edema(CME) due to Branch Retinal Vein Occlusion (BRVO). Indian J Clin Exp Ophthalmol 2021;7(1):194-198

Copyright © 2021 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)